Title: Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
Vote to pass a bill extends the temporary scheduling order for fentanyl-related substances until May 6, 2021.
Conduct a study of the classification of fentanyl-related substances as Schedule I controlled substances under the Controlled Substances Act, research fentanyl-related substances, and the importation of fentanyl-related substances into the US; and
Submit a report on the results of the study to:
The House and Senate Judiciary Committees;
The Senate Health, Education, Labor, and Pensions Committee;
The Senate International Narcotics Control Caucus; and
The House Energy and Commerce Committee.
Requires the Comptroller General to consider the views of experts from non-federal entities when conducting the study and developing the report, including experts from (Sec. 3):
The scientific and medical research community;
The state and local law enforcement community; and
The civil rights and criminal justice reform communities.
Requires the Comptroller General, when conducting the study and developing the report, to (Sec. 3):
Evaluate class control of fentanyl-related substances, including:
The definition of the class of fentanyl-related substances, including the process by which the definition was formulated;
The potential for classifying fentanyl-related substances with no or low abuse potential, or potential accepted medical use, as schedule I controlled substances when scheduled as a class; and
Any known classification of fentanyl-related substances with no or low abuse potential, or potential accepted medical use;
Review the impact or potential impact of controls on fentanyl-related substances on public health and safety, including on:
Diversion risks, overdose deaths, and law enforcement encounters with fentanyl-related substances; and
Federal law enforcement investigations and prosecutions of offenses related to fentanyl-related substances;
Review the impact of international regulatory controls on fentanyl-related substances on the supply of such substances to the US, including by China; and
Recommend best practices for accurate, swift, and permanent control of fentanyl-related substances, including:
How to quickly remove from the schedules under the Controlled Substances Act substances that are determined to have no abuse potential; and
How to reschedule substances that are determined to have a low abuse potential or potential accepted medical use.